Thomas J. Schall Chemo Centryx, Inc. (CCXI) insider trading activity

CCXI Quotes by TradingView

Thomas J. Schall is President and CEO of ChemoCentryx, Inc.. Currently has a direct ownership of 0 shares of CCXI, which is worth approximately $0. The most recent transaction as insider was on Oct 20, 2022, when has been sold 2,393,352 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Thomas J. Schall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2022
SELL
Sale (or disposition) back to the issuer
-
2,393,352 Reduced 100.0%
0 Common Stock
Aug 04 2022
SELL
Open market or private sale
$6,531,200 $50.24 p/Share
130,000 Reduced 5.15%
2,393,352 Common Stock
Aug 04 2022
BUY
Exercise of conversion of derivative security
$1,856,400 $14.28 p/Share
130,000 Added 4.9%
2,523,352 Common Stock
Jan 01 2022
SELL
Payment of exercise price or tax liability
$1,663,864 $36.41 p/Share
45,698 Reduced 1.87%
2,393,352 Common Stock
Jan 01 2022
BUY
Exercise of conversion of derivative security
-
84,234 Added 3.34%
2,439,050 Common Stock
Dec 01 2021
BUY
Exercise of conversion of derivative security
$564,553 $12.29 p/Share
45,936 Added 1.91%
2,354,816 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$2,945,906 $61.92 p/Share
47,576 Reduced 2.02%
2,308,880 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
87,899 Added 3.6%
2,356,456 Common Stock
Dec 15 2020
SELL
Open market or private sale
$1,145,411 $65.01 p/Share
17,619 Reduced 0.77%
2,268,557 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$252,128 $14.31 p/Share
17,619 Added 0.76%
2,286,176 Common Stock
Dec 14 2020
SELL
Open market or private sale
$725,280 $65.03 p/Share
11,153 Reduced 0.49%
2,268,557 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$159,599 $14.31 p/Share
11,153 Added 0.49%
2,279,710 Common Stock

Also insider at

IMRX
Immuneering Corp Healthcare
Director
TJS

Thomas J. Schall

President and CEO
San Carlos, CA

Track Institutional and Insider Activities on CCXI

Follow ChemoCentryx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCXI shares.

Notify only if

Insider Trading

Get notified when an Chemo Centryx, Inc. insider buys or sells CCXI shares.

Notify only if

News

Receive news related to ChemoCentryx, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CCXI